A carregar...
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
OBJECTIVE: There is increasing pre-clinical evidence indicating that metformin, a medication commonly used for type 2 diabetes, may protect against cancer. Motivated by this emerging evidence we asked two questions: (a) can metformin prevent ovarian cancer growth by altering metabolism, and (b) will...
Na minha lista:
| Publicado no: | Am J Obstet Gynecol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4387077/ https://ncbi.nlm.nih.gov/pubmed/25446664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2014.10.026 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|